Saha Cardiovascular Research Center, Biomedical Biological Sciences Research Building, B243, University of Kentucky, Lexington, KY 40536-0509, USA.
Curr Atheroscler Rep. 2012 Oct;14(5):402-12. doi: 10.1007/s11883-012-0271-y.
Abdominal aortic aneurysms (AAAs) are a common but asymptomatic disease that has high susceptibility to rupture. Current therapeutic options are limited to surgical procedures because no pharmacological approaches have been proven to decrease either expansion or rupture of human AAAs. The current dearth of effective medical treatment is attributed to insufficient understanding of the mechanisms underlying the initiation, propagation and rupture of AAAs. This review will emphasize recent advances in mechanistic studies that may provide insights into potential pharmacological treatments for this disease. While we primarily focus on recent salient findings, we also discuss mechanisms that continue to be controversial depending on models under study. Despite the progress on exploring mechanisms of experimental AAAs, ultimate validation of mechanisms will require completion of prospective double-blinded clinical trials. In addition, we advocate increased emphasis of collaborative studies using animal models and human tissues for determination of mechanisms that explore expansion and rupture of existing AAAs.
腹主动脉瘤(AAA)是一种常见但无症状的疾病,易发生破裂。目前的治疗选择仅限于手术,因为没有药物治疗方法被证明可以减少人类 AAA 的扩张或破裂。目前缺乏有效的药物治疗方法,这归因于对 AAA 起始、传播和破裂的机制的了解不足。这篇综述将强调在可能为这种疾病提供潜在药物治疗的机制研究方面的最新进展。虽然我们主要关注最近的显著发现,但我们也讨论了根据研究模型仍然存在争议的机制。尽管在探索实验性 AAA 机制方面取得了进展,但最终验证机制仍需要完成前瞻性双盲临床试验。此外,我们主张通过使用动物模型和人类组织进行合作研究,以确定探索现有 AAA 扩张和破裂的机制,从而更加重视这方面的研究。